Deka Biosciences is a startup based in Germany, 1 tracked investor.
Deka Biosciences is a company headquartered in Germany. Brouky records 1 investor associated with the company.
Deka Biosciences develops disease-specific “Diakines,” therapeutic constructs that combine dual and complementary cytokines intended to improve pharmacokinetics and pharmacodynamics by promoting targeted accumulation of cytokines in affected tissues and by tailoring immune responses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.